Due to the diverse functions of JAK family members in various tissues and cell types, JAK1-selective inhibitors were developed and are used for the treatment of atopic dermatitis but remain under clinical evaluation for the treatment of asthma. The gene discussed is JAK1; the disease is atopic eczema.